Sage’s medical chief is latest leader to leave biotech
As Sage Therapeutics Inc. contemplates its path forward after rejecting a buyout offer from Biogen, its top executive ...
Sage Therapeutics resumed with an Underperform at BofA
BofA resumed coverage of Sage Therapeutics (SAGE) with an Underperform rating and $5 price target. The impact of Biogen’s (BIIB) unsolicited ...
Hosted on MSN20d
Closure of local clinic raises concerns over access and wait times for El Paso veterans
The pending closure of Desert Sage Medical Clinic in West El Paso, announced in December, is leaving veterans and their families without accessible medical treatment. The clinic currently treats a ...
Sage Therapeutics Chief Medical Officer to step down
Sage Therapeutics (SAGE) announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the ...
Hosted on MSN14d
Discover the health and memory benefits of sage
In a world where more and more people are seeking natural alternatives to boost their health, sage stands out as a plant with surprising properties.
pharmaphorum3d
Sage sues Biogen after unsolicited takeover bid
Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal. Specific details of the lawsuit are not yet available ...